| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/31/2001 | US6268379 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 07/31/2001 | US6268378 Integrin receptor antagonists |
| 07/31/2001 | US6268360 Urination delay |
| 07/31/2001 | US6268308 Herbicidal S-substituted 1,2,4,6-thiatriazines |
| 07/31/2001 | US6268163 Identification of drug candidates modulating factor VII-mediated intracellular signaling |
| 07/31/2001 | CA2040774C Compounds formed from o-hydroxyphenyl-1,3,5-triazines and sterically hindered amines |
| 07/26/2001 | WO2001053299A1 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 07/26/2001 | WO2001053298A1 Imidazopyridines and related azacyclic derivatives as selective modulators of bradykinin b2 receptors |
| 07/26/2001 | WO2001053297A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053274A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | WO2001053273A1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 07/26/2001 | WO2001053268A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 07/26/2001 | WO2001053266A1 Therapeutic morpholino-substituted compounds |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001052855A2 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 07/26/2001 | WO2001008663A3 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 07/26/2001 | US20010009916 Anxiolytic, hypotensive agents, schizophrenia, Parkinson's disease, lowering blood pressure, migraine headaches; 5-amino-5,6-dihydro-4H-imidazo( 4,5,1-ij) quinolin-2-one compounds |
| 07/26/2001 | US20010009914 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 07/26/2001 | US20010009911 Isomers, hydrates, solvates and addition salts in treatment of endothelial dysfunction disease such as atherosclerosis, dyslipidaemia; antidiabetic agents; heart transplantation; inhibition of nitrogen monoxide synthase and oxidative stress |
| 07/26/2001 | CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 07/26/2001 | CA2397665A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397597A1 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 07/26/2001 | CA2396066A1 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 07/26/2001 | CA2394703A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | CA2388885A1 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 07/25/2001 | EP1118615A1 Novel salts of pyridopyrazine compound and crystals thereof |
| 07/25/2001 | EP1118322A1 Drugs for improving vesical excretory strength |
| 07/25/2001 | EP1117664A1 Imidazo[4,5-c-]-pyridine-4-one derivatives with factor xa inhibiting effect |
| 07/25/2001 | EP1117651A1 New bis-benzimidazoles |
| 07/25/2001 | EP1117642A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 07/25/2001 | EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 07/25/2001 | EP1117402A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117401A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117297A1 Synthetic analogs of ecteinascidin-743 |
| 07/25/2001 | EP0877745B1 N-( 1,2,4] triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
| 07/25/2001 | EP0876366B1 Angiogenesis inhibiting pyridazinamines |
| 07/25/2001 | EP0783501B9 pyrimidone derivatives with antifungal activity |
| 07/25/2001 | CN1305481A Piperazino derivatives as neurokinin antafonists |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305378A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal fragility |
| 07/25/2001 | CN1304938A Process for preparing sophocarpine |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/25/2001 | CN1068882C Process for preparation of 5-(alkoxymethyl)-2,3-pyridinedicarboximide compounds |
| 07/24/2001 | US6265577 Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265431 Cycloalkano-indole and -azaindole derivatives |
| 07/24/2001 | US6265419 Irritable bowel disorder |
| 07/24/2001 | US6265418 N-acylamino acid amide compounds and intermediates for preparation thereof |
| 07/24/2001 | US6265416 Anticoagulants |
| 07/24/2001 | US6265415 Compounds for inhibition of gastric acid secretion |
| 07/24/2001 | US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/24/2001 | US6264987 Method for preparing microparticles having a selected polymer molecular weight |
| 07/24/2001 | CA2230303C Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin |
| 07/24/2001 | CA2218503C Arylsulfonyl hydroxamic acid derivatives |
| 07/24/2001 | CA2174033C Novel pyridine compounds; process for preparing the same and pharmaceutical compositions containing them |
| 07/24/2001 | CA2171972C Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| 07/24/2001 | CA2042112C N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| 07/19/2001 | WO2001051486A2 Process and intermediates for the preparation of imidazopyridines |
| 07/19/2001 | WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists |
| 07/19/2001 | WO2001012632A3 Phenanthroline-7-one derivatives and their therapeutic uses |
| 07/19/2001 | WO2001012631A3 Ascididemin derivatives and their therapeutic applications |
| 07/19/2001 | WO2001005758A3 Indoles and indazoles for the treatment of migraine |
| 07/19/2001 | CA2396028A1 Process and intermediates for the preparation of imidazopyridines |
| 07/19/2001 | CA2396007A1 Piperidine and piperazine derivatives |
| 07/18/2001 | EP1116716A1 Piperidine and piperazine compounds for use in the treatment of Alzheimer |
| 07/18/2001 | EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 07/18/2001 | EP1115725A1 Tetrahydropyridoethers |
| 07/18/2001 | EP1115402A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas |
| 07/18/2001 | EP0639083B1 Complexing agents and targeting immunoreagents |
| 07/18/2001 | CN1304411A Acetylcholine enhancers |
| 07/18/2001 | CN1304402A Sulfonamide derivatives |
| 07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 07/18/2001 | CN1068593C Process for preparing 2-alkoxyphenoxy sulfuric urea with heterocylic ring |
| 07/17/2001 | US6262268 Process and intermediates to a tetrahydro-[1,8]-naphthyridine |
| 07/17/2001 | US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents |
| 07/17/2001 | US6262100 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests |
| 07/17/2001 | US6262066 High affinity ligands for nociceptin receptor ORL-1 |
| 07/17/2001 | US6262065 Swainsonine derivatives and methods for preparing the same |
| 07/17/2001 | US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation |
| 07/17/2001 | CA2157860C 5,6-dihydro-4h-imidazo [4,5,1-ij] quinolines, processes for their preparation, their use as medicaments, and intermediate compounds |
| 07/12/2001 | WO2001049721A2 Bacterial genes and proteins that are essential for cell viability and their uses |
| 07/12/2001 | WO2001049700A1 Imidazopyrimidine nucleoside analogues with anti-hiv activity |
| 07/12/2001 | WO2001049682A1 Condensed azepines as vasopressin agonists |
| 07/12/2001 | WO2001049681A1 A method for the preparation of substituted benzene derivatives |
| 07/12/2001 | WO2001049678A1 Substituted phenyl-piperazine derivatives, their preparation and use |
| 07/12/2001 | WO2001049676A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | WO2001049269A1 Sustained-releasing anthelmintic compositions comprising praziquantel |
| 07/12/2001 | US20010007905 Nucleic acids labelled with extended rhodamine dyes |
| 07/12/2001 | US20010007869 Alpha-substittuted pyridazino quinoline compounds |
| 07/12/2001 | US20010007867 Substituted 6,5-hetero-bicyclic derivatives |
| 07/12/2001 | DE19963868A1 Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New substituted piperidines, pharmaceutical compositions containing them and methods for their preparation |
| 07/12/2001 | DE19962470A1 Verwendung von Chemotherapeutika Use of chemotherapeutic agents |
| 07/12/2001 | DE10000739A1 New piperidine and piperazine derivatives which are antagonists of certain serotonin receptors, are useful in treatment of, e.g. eating disorders, stroke, anxiety or Parkinson's disease |
| 07/12/2001 | CA2396257A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | CA2396040A1 Novel bacterial genes and proteins that are essential for cell viability and their uses |